Technology

Our expertise drives innovation, development, and application of informatics and software that continue to enable leading pharmaceutical, environmental, food & beverage and chemical materials organizations to accelerate decision-making, improve laboratory effectiveness, and get products to market faster.

  • New SELECT SERIES MRT Redefines Performance of Next Generation High Resolution Mass Spectrometry

      Are you ready for the next generation of high resolution mass spectrometry (HRMS) platforms? The state-of-the-art hybrid quadrupole Time-of-Flight (Q-ToF) SELECT SERIES MRT is a groundbreaking addition to Waters’ SELECT SERIES family. Incorporating Multi Reflecting Time-of-Flight (MRT) technology, the SELECT SERIES MRT provides a unique combination of high resolution and specificity independent of scan…

  • Supercharging Mass Spectrometry in the Fight Against SARS-CoV-2

    Waters’ latest product launch will supercharge the role of mass spectrometry research in the fight against SARS-CoV-2. Scientists can now directly quantify specific viral NCAP peptides in a highly reproducible manner with the Waters SARS-CoV-2 LC-MS Kit (RUO), allowing breakthrough research of the SARS-CoV-2 virus.

  • The Quest for Maximum LC Performance: A Well-Packed Column Bed

    As chromatographers seek maximum separation performance on their liquid chromatography (LC) systems, a key factor is the use of LC columns with an optimally packed column bed density. Solid-core columns manufactured with strict quality control for their packed bed density enable top efficiency, mechanical stability, and performance – no matter how tough your method conditions….

  • Recent Trends in Beverage Testing – Vitamins

    Driven by the global COVID-19 pandemic, consumers increasingly seek food and beverages that support immunity and health. As a result, the global functional beverages market is expected to grow to $158 billion in 2023. Waters HPLC and UPLC solutions enable reliable, accurate, and efficient testing methods to ensure that finished beverage products meet manufacturers’ specifications and nutritional label claims.

  • Avoiding a PCR Reagent Crunch: The Role of Preparative HPLC Columns

    Critical SARS-CoV-2 PCR based diagnostics have not been immune to the supply chain disruptions so common during the COVID-19 pandemic. While the biggest disruption for PCR based testing was RNA extraction kits, enzymes and PCR primers have been affected as well. At Waters, we’ve kept a close eye on the role that high-quality preparative HPLC columns play in the PCR primer and probe supply chain. As we forge ahead through this pandemic and beyond, we will continue to help ensure adequate quality and supply of PCR primers and probes for diagnostics and routine use.

  • Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM

    The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification variants (attributes) creates an interesting analytical challenge for scientists tasked with their characterization and then with monitoring those attributes important…

  • Embracing Analytical Techniques Into Regulated Laboratories

    To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.

  • Comprehending COVID-19: How Consumables Can Increase LC-MS/MS Sensitivity

    During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological specimen, the sample collection medium, the viral load threshold, and the need for a high throughput method gave rise to…

  • Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis

    Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing great success as new gene-based therapeutics that hold tremendous promise. With a string of recent drug approvals, including the first…

  • Tools for Chromatographic Success: Three Ways to Support Data Quality in Routine Analysis

    Avoiding the pitfalls of data quality and integrity in the Pharma QC laboratory while running routine analyses is an ongoing challenge. Regulatory violations are frequently a result of a lack of complete data, suspect data, and improper audit trails. A recent report from Deloitte stated that data integrity violations account for over 70% of the…

  • Boosting Biopharma Productivity with Routine LC-MS

    As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to unleash their creativity and make pioneering scientific breakthroughs. Scientists working within the rapidly growing biopharmaceutical industry are no exception. With…